• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

条件净生存率:结直肠癌幸存者的相关预后信息。一项基于法国人群的研究。

Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study.

作者信息

Drouillard Antoine, Bouvier Anne-Marie, Rollot Fabien, Faivre Jean, Jooste Valérie, Lepage Côme

机构信息

Digestive Cancer Registry of Burgundy, INSERM U866, University Hospital Dijon, University of Burgundy, Dijon, France.

Digestive Cancer Registry of Burgundy, INSERM U866, University Hospital Dijon, University of Burgundy, Dijon, France.

出版信息

Dig Liver Dis. 2015 Jul;47(7):597-601. doi: 10.1016/j.dld.2015.03.013. Epub 2015 Mar 27.

DOI:10.1016/j.dld.2015.03.013
PMID:25911573
Abstract

BACKGROUND

Traditionally, survival estimates have been reported as survival from the time of diagnosis. A patient's probability of survival changes according to time elapsed since the diagnosis and this is known as conditional survival. The aim was to estimate 5-year net conditional survival in patients with colorectal cancer in a well-defined French population at yearly intervals up to 5 years.

METHODS

Our study included 18,300 colorectal cancers diagnosed between 1976 and 2008 and registered in the population-based digestive cancer registry of Burgundy (France). We calculated conditional 5-year net survival, using the Pohar Perme estimator, for every additional year survived after diagnosis from 1 to 5 years.

RESULTS

The initial 5-year net survival estimates varied between 89% for stage I and 9% for advanced stage cancer. The corresponding 5-year net survival for patients alive after 5 years was 95% and 75%. Stage II and III patients who survived 5 years had a similar probability of surviving 5 more years, respectively 87% and 84%. For survivors after the first year following diagnosis, five-year conditional net survival was similar regardless of age class and period of diagnosis.

CONCLUSIONS

For colorectal cancer survivors, conditional net survival provides relevant and complementary prognostic information for patients and clinicians.

摘要

背景

传统上,生存估计报告为自诊断之时起的生存情况。患者的生存概率会根据自诊断以来经过的时间而变化,这被称为条件生存。目的是在一个明确界定的法国人群中,对结直肠癌患者每年进行一次直至5年的5年净条件生存估计。

方法

我们的研究纳入了1976年至2008年间诊断的18300例结直肠癌病例,这些病例登记在法国勃艮第基于人群的消化道癌症登记处。我们使用波哈尔·佩尔梅估计器计算了诊断后存活1至5年中每多存活一年的条件5年净生存情况。

结果

最初的5年净生存估计在I期的89%和晚期癌症的9%之间变化。5年后仍存活的患者相应的5年净生存为95%和75%。存活5年的II期和III期患者再存活5年的概率相似,分别为87%和84%。对于诊断后第一年存活的患者,无论年龄组和诊断时期如何,5年条件净生存情况相似。

结论

对于结直肠癌幸存者,条件净生存为患者和临床医生提供了相关且互补的预后信息。

相似文献

1
Conditional net survival: Relevant prognostic information for colorectal cancer survivors. A French population-based study.条件净生存率:结直肠癌幸存者的相关预后信息。一项基于法国人群的研究。
Dig Liver Dis. 2015 Jul;47(7):597-601. doi: 10.1016/j.dld.2015.03.013. Epub 2015 Mar 27.
2
Long-term net survival in patients with colorectal cancer in France: an informative contribution of recent methodology.法国结直肠癌患者的长期净生存:近期方法学的有益贡献。
Dis Colon Rectum. 2013 Oct;56(10):1118-24. doi: 10.1097/DCR.0b013e31829f3436.
3
Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods.癌症登记数据的净生存:新无偏 Pohar-Perme 估计器的使用和经典方法的偏差幅度。
Int J Cancer. 2013 May 15;132(10):2359-69. doi: 10.1002/ijc.27830. Epub 2012 Oct 3.
4
Conditional survival for long-term colorectal cancer survivors in the Netherlands: who do best?荷兰长期结直肠癌幸存者的条件生存情况:谁做得最好?
Eur J Cancer. 2014 Jul;50(10):1731-1739. doi: 10.1016/j.ejca.2014.04.009. Epub 2014 May 6.
5
Probabilities of dying from cancer and other causes in French cancer patients based on an unbiased estimator of net survival: a study of five common cancers.基于净生存无偏估计的法国癌症患者癌症和其他原因死亡概率:五种常见癌症的研究。
Cancer Epidemiol. 2013 Dec;37(6):857-63. doi: 10.1016/j.canep.2013.08.006. Epub 2013 Sep 22.
6
Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.癌症患者的条件相对生存率和条件死亡概率:一项法国国家数据库分析。
Cancer. 2009 Oct 1;115(19):4616-24. doi: 10.1002/cncr.24489.
7
Aspects of survival from colorectal cancer in Denmark.丹麦结直肠癌的生存情况
Dan Med J. 2012 Apr;59(4):B4428.
8
Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers.欧洲癌症患者条件生存的临床意义:13 种癌症的年龄特异性分析。
J Clin Oncol. 2010 May 20;28(15):2520-8. doi: 10.1200/JCO.2009.25.9697. Epub 2010 Apr 20.
9
Net survival in recurrence-free colon cancer patients.无复发生存期的结肠癌患者。
Cancer Epidemiol. 2019 Aug;61:124-128. doi: 10.1016/j.canep.2019.06.001. Epub 2019 Jun 15.
10
Unbiased estimates of long-term net survival of hematological malignancy patients detailed by major subtypes in France.法国详细描述了主要亚型的血液病患者的长期净生存率的无偏估计。
Int J Cancer. 2013 May 15;132(10):2378-87. doi: 10.1002/ijc.27889. Epub 2012 Oct 30.

引用本文的文献

1
Detection of Glycosylated Markers From Cancer Stem Cells With ColoSTEM Dx Kit for Earlier Prediction of Colon Cancer Aggressiveness.使用ColoSTEM Dx试剂盒检测癌症干细胞中的糖基化标志物,以便更早预测结肠癌侵袭性。
Front Oncol. 2022 Jul 22;12:918702. doi: 10.3389/fonc.2022.918702. eCollection 2022.
2
Integrated Chinese Herbal Medicine and Western Medicine on the Survival in Patients with Colorectal Cancer: A Retrospective Study of Medical Records.中西医结合治疗对结直肠癌患者生存的影响:一项病历回顾性研究
Evid Based Complement Alternat Med. 2020 Jan 13;2020:4561040. doi: 10.1155/2020/4561040. eCollection 2020.
3
Changes in conditional net survival and dynamic prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy.
新诊断转移性前列腺癌患者初始接受雄激素剥夺治疗后条件净生存和动态预后因素的变化。
Cancer Med. 2019 Nov;8(15):6566-6577. doi: 10.1002/cam4.2502. Epub 2019 Sep 11.
4
Prognostic factors and survival of colorectal cancer in Kurdistan province, Iran: A population-based study (2009-2014).伊朗库尔德斯坦省结直肠癌的预后因素与生存率:一项基于人群的研究(2009 - 2014年)
Medicine (Baltimore). 2017 Feb;96(6):e5941. doi: 10.1097/MD.0000000000005941.